Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Cash Flow Quality Index
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Cash Flow Quality Index of 0.55x as of September 2025. Operating cash flow of CN¥29.28 Million is below net income of CN¥53.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Fujian Aonong Biological Technology Grou (603363) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Fujian Aonong Biological Technology Group Incorporation Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603363 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd (2014–2024)
Year-by-year earnings quality comparison for Fujian Aonong Biological Technology Group Incorporation Ltd. For live market cap and the full company financial profile, see 603363 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.85x | CN¥-116.78 Million | CN¥63.09 Million | ▼ -553.0% |
| 2020 | 0.41x | CN¥406.02 Million | CN¥993.61 Million | ▼ -89.6% |
| 2019 | 3.93x | CN¥394.16 Million | CN¥100.36 Million | ▲ +47.6% |
| 2018 | 2.66x | CN¥27.26 Million | CN¥10.24 Million | ▲ +1113.5% |
| 2017 | 0.22x | CN¥26.78 Million | CN¥122.08 Million | ▼ -81.6% |
| 2016 | 1.19x | CN¥128.95 Million | CN¥108.35 Million | ▼ -64.4% |
| 2015 | 3.34x | CN¥129.24 Million | CN¥38.69 Million | ▲ +489.2% |
| 2014 | -0.86x | CN¥-33.66 Million | CN¥39.22 Million | — |